Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig F Munns

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
Pediatric Radiology|October 5, 2018
Differential diagnosis of perinatal hypophosphatasia: radiologic perspectivesAmaka C Offiah, Jerry Vockley, Craig F Munns, et al.
Diabetes Care|July 21, 2021
Bone Mineral Density and Type 1 Diabetes in Children and Adolescents: A Meta-analysisPhoebe Loxton, Kruthika Narayan, Craig F Munns, et al.
JBMR Plus|September 6, 2019
FGF23, Hypophosphatemia, and Emerging TreatmentsErik A Imel, Andrew Biggin, Aaron Schindeler, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 23, 2012
Zoledronic acid improves bone mineral density in pediatric spinal cord injuryHooi Leng Ooi, Julie Briody, Mary McQuade, et al.
Bone|June 23, 2004
Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfectaCraig F Munns, Frank Rauch, Richard J Mier, et al.
Pediatric Blood & Cancer|April 30, 2013
Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: a retrospective analysisBhavna Padhye, Luciano Dalla-Pozza, David G Little, et al.
JBMR Plus|May 17, 2023
Craniosynostosis in Patients With X-Linked Hypophosphatemia: A ReviewCraig F Munns, Edward P Maguire, Angela Williams, et al.
Bone|May 30, 2006
Vertebral morphometry in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate treatmentChristof Land, Frank Rauch, Craig F Munns, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 5, 2009
Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled studyFrank Rauch, Craig F Munns, Christof Land, et al.
JBMR Plus|January 12, 2026
Denosumab as a treatment for pediatric hypercalcemia-a multicenter experienceAnnabelle Hobbs, Rishi Nair, Karissa Ludwig, et al.
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
Pediatric Radiology|October 5, 2018
Differential diagnosis of perinatal hypophosphatasia: radiologic perspectivesAmaka C Offiah, Jerry Vockley, Craig F Munns, et al.
Diabetes Care|July 21, 2021
Bone Mineral Density and Type 1 Diabetes in Children and Adolescents: A Meta-analysisPhoebe Loxton, Kruthika Narayan, Craig F Munns, et al.
JBMR Plus|September 6, 2019
FGF23, Hypophosphatemia, and Emerging TreatmentsErik A Imel, Andrew Biggin, Aaron Schindeler, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 23, 2012
Zoledronic acid improves bone mineral density in pediatric spinal cord injuryHooi Leng Ooi, Julie Briody, Mary McQuade, et al.
Bone|June 23, 2004
Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfectaCraig F Munns, Frank Rauch, Richard J Mier, et al.
Pediatric Blood & Cancer|April 30, 2013
Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: a retrospective analysisBhavna Padhye, Luciano Dalla-Pozza, David G Little, et al.
JBMR Plus|May 17, 2023
Craniosynostosis in Patients With X-Linked Hypophosphatemia: A ReviewCraig F Munns, Edward P Maguire, Angela Williams, et al.
Bone|May 30, 2006
Vertebral morphometry in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate treatmentChristof Land, Frank Rauch, Craig F Munns, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 5, 2009
Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled studyFrank Rauch, Craig F Munns, Christof Land, et al.
JBMR Plus|January 12, 2026
Denosumab as a treatment for pediatric hypercalcemia-a multicenter experienceAnnabelle Hobbs, Rishi Nair, Karissa Ludwig, et al.
Pageof 13